Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous advers...
Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
We evaluated the cost and efficiency of routine HLA-B*15 ∶ 02 screening to prevent carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (CBZ-SJS/TEN) in Hong Kong.
Data were extracted from patients who commenced CBZ as the first-ever AED treatment or tested for HLA-B*15 ∶ 02 allele in three years before policy implementa...
Alternative Titles
Full title
Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1522141023
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1522141023
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0096990
